Inipant

Pantoprazole, the active ingredient in Inipant, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, peptic ulcers, and Zollinger‑Ellison syndrome.

GNH USA supplies Inipant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable sourcing for bulk and retail needs. Customers benefit from consistent batch release testing and on‑time delivery across global markets.

Pantoprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by reducing gastric acidity. - Erosive oesophagitis: promotes healing of inflamed esophageal tissue. - Peptic ulcer disease: supports ulcer resolution by maintaining a less acidic environment. - Helicobacter pylori eradication (as part of combination therapy): enhances antibiotic effectiveness by suppressing acid. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Pantoprazole may cause a range of adverse reactions, which are generally categorized by frequency.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Clostridioides difficile infection - Hypomagnesemia (low magnesium levels) - Elevated liver enzymes - Bone fractures with long‑term use - Acute interstitial nephritis

When prescribing Pantoprazole, clinicians should consider several precautionary measures to ensure safe use.

- Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged therapy may cause hypomagnesemia. - Evaluate for H. pylori infection: consider combination therapy when appropriate. - Avoid long‑term use unless necessary: risk of fractures and infections increases with extended treatment. - Store at room temperature: keep in original container, protect from moisture.

Pantoprazole can interact with other medicines, altering their effectiveness or safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption. - Methotrexate (high dose): increased toxicity. - Warfarin: potential INR elevation. - Digoxin: reduced absorption.

Moderate Interactions (Monitor Closely): - Diazepam: increased serum levels. - Phenytoin: decreased levels. - Fluconazole: increased pantoprazole exposure. - Ketoconazole: reduced absorption. - Iron supplements: decreased absorption if taken together.